Analysis of hepatitis C virus isolates by serotyping and genotyping

Journal of Clinical Microbiology

Volumn 34, Issue 7, 1996, Pages 1784-1787

  Van Doorn, Leen Jan ^a   Kleter, Bernhard ^a   Pike, Ian ^b   Quint, Wim ^a  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b Murex Diagnostics Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ARTICLE; DIAGNOSTIC VALUE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROTYPE;

EID: 0030007041     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.7.1784-1787.1996     Document Type: Article

References (39)

1. Bhattacherjee, V., L. E. Prescott, I. Pike, B. Rodgers, H. Bell, A. R. El-Zayadi, M. C. Kew, J. Conradie, C. K. Lin, H. Marsden, A. A. Saeed, D. Parker, P. L. Yap, and P. Simmonds. 1995. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76:1737-1748.
2. Bukh, J., P. Wantzin, K. Krogsgaard, F. Knudsen, R. H. Purcell, and R. H. Miller. 1993. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J. Infect. Dis. 168:1343-1348.
3. Chan, S.-W., P. Simmonds, F. McOmish, P. L. Yap, R. Mitchell, B. Dow, and E. Follelt. 1991. Serological reactivity of blood donors infected with three different types of hepatitis C virus. Lancet 338:1391.
4. Chemello, L., D. Cavalletto, P. Pontisso, F. Bortolotti, C. Donada, V. Donadon, M. Frezza, P. Casarin, and A. Alberti. 1993. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 17:179-182.
5. Dusheiko, G., H. Schmilovitz-Weiss, D. Brown, F. McOmish, P. L. Yap, S. Sherlock, N. McIntyre, and P. Simmonds. 1994. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
6. Féra;, C., M. Gigou, D. Samuel, V. Paradis, S. Mishiro, G. Maertens, M. Reynes, H. Okamoto, H. Bismuth, and C. Bréchet. 1995. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108:1088-1096.
7. Lau, J. Y. N., P. Simmonds, and M. Urdea. 1995. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 346:425-426.
8. Machida, A., H. Ohnuma, F. Tsuda, E. Munekata, T. Tanaka, Y. Akahane, H. Okamoto, and S. Mishiro. 1992. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 16:886-891.
9. Maertens, G., A. Ducatteeuw, L. Stuyver, P. Vandeponseele, A. Venneman, A. Wyseur, R. Heijtink, and G. de Martinoff. 1994. Low prevalence of anti-E1 antibodies reactive to recombinant type 1b El envelope protein in type 2, 3, and 4 HCV sera, but high prevalence in subtypes 1a and 1b. Viral Hepatitis Liver Dis. 1994:314-316.
10. McOmish, F., S.W. Chan, B. C. Dow, J. Gillon, W. D. Frame, R. J. Crawford, P. L. Yap, E. Follett, and P. Simmonds. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion (Bethesda) 33:7-13.
11. McOmish, F., P. L. Yap, B. C. Dow, E. A. C. Follett, C. Seed, A. J. Keller, T. J. Cobain, R. Krusius, E. Kolho, R. Naukkarinen, C. Lin, C. Lai, S. Leong, G. A. Medgyesi, M. Hejjas, H. Kiyokawa, K. Fukada, T. Cuypers, A. A. Saeed, A. M. Al-Rasheed, M. Lin, and P. Simmonds. 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32:884-892.
12. Medin, C., T. Allander, M. Roll, S. H. Jacobson, and L. Grillner. 1993. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study. Nephron 65:40-45.
13. Mizui, M., T. Moriya, F. Sasaki, T. Nakanishi, H. Ichimura, N. Ohono, and H. Yoshizawa. 1994. Relation between HCV genotypes and the prevalence of antibodies against 5-1-1 and C100-3 in Japanese blood donors seropositive for hepatitis C virus. Int. Hepatol. Commun. 2:183-185.
14. Mondelli, M. U., A. Cerino, F. Bono, A. Cividini, A. Maccabruni, M. Arico, A. Malfitano, G. Barbarini, V. Piazza, L. Minoli, and E. Silini. 1994. Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J. Clin. Microbiol. 32:2523-2527.
15. Nagayama, R., F. Tsuda, H. Okamoto, Y. Wang, T. Mitsui, T. Tanaka, Y. Miyakawa, and M. Mayumi. 1993. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with the C100-3 protein. J. Clin. Invest. 92:1529-1533.
16. Okamoto, H., Y. Sugiyama, S. Okada, K. Kurai, Y. Akahane, Y. Sugai, T. Tanaka, K. Sato, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73:673-679.
17. Oliva, J. A., R. M. Maymo, J. Carrio, O. Delgado, and J. M. Mallafre. 1993. Late seroconversion of C virus markers in hemodialysis patients. Kidney Int. 43(Suppl. 41):S153-S156.
18. Onto, E., M. Mizokami, N. Mizoguchi, K. I. Ohba, M. Tohnai, H. Yamanaka, T. Oguri, N. Hiroshima, T. Koide, H. Kano, K. Tsukiyama-Kohara, M. Kohara, and J. Y. N. Lau. 1994. Hepatitis C virus serotype II responds more favorably to interferon-alfa therapy. J. Hepatol. 21:130-132.
19. Pawlotsky, J. M., L. Tsakiris, F. Roudot-Thoraval, C. Pellet, L. Stuyver, J. Duval, and D. Dhumeaux. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. Infect. Dis. 171:1607-1610.
20. Pontisso, P., M. Gerotto, L. Chemello, C. Casarin, S. Tisminetzky, F. Bar alle, and A. Alberti. 1995. Hepatitis C virus genotypes HCV-1a and HCV-1b: the clinical point of view. J. Infect. Dis. 171:760.
21. Pozzato, G., S. Kaneko, M. Moretti, L. S. Crocé, F. Franzin, M. Unoura, L. Bereich, C. Tiribelli, M. Crovatto, G. Santini, and K. Kobayashi, 1994. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J. Med. Virol. 43:291-296.
22. Pozzatto, G., M. Moretti, F. Franzin, L. S. Crocé, C. Tiribelli, T. Masayu, S. Kaneko, M. Unoura, and K. Kobayashi. 1991. Severity of liver disease with different hepatitis C viral clones. Lancet 338:509.
23. Qu, D., L. Vitvitski, S. Mechai, F. Berby, S.-P. Tong, F. Bailly, Q.-S. Wang, J.-L. Martin, and C. Trépo. 1994. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and II. J. Hepatol. 21:70-75.
24. Silini, E., F. Bono, A. Cividini, A. Cerino, S. Bruno, S. Rossi, G. Belloni, B. Brugnetti, E. Civardi, L. Salvaneschi, and M. Mondelli. 1995. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21:285-290.
25. Simmonds, P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
26. Simmonds, P., A. Alberti, H. J. Alter, et al. 1994. A proposed system for nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
27. Simmonds, P., K. A. Rose, S. Graham, S. W. Chan, F. McOmish, B. C. Dow, E. A. C. Follett, P. L. Yap, and H. Marsden. 1993. Mapping of serotypespecific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31:1493-1503.
28. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, and G. Maertens. 1993. Typing of HCV isolates and characterization of new (sub)types using a line probe assay. J. Gen. Virol. 74:1092-1102.
29. Stuyver, L., W. van Arnhem, A. Wyseur, R. DeLeys, and G. Maertens. 1993. Analysis of the putative E1 envelope and NS4a epitope regions of the HCV type 3. Biochem. Biophys. Res. Commun. 192:635-641.
30. Stuyver, L., A. Wyseur, W. van Arnhem, F. Lunel, P. Laurent-Puig, J. M. Pawlotsky, B. Kieler, L. Bassit, J. Nkengasong, L. J. van Doom, and G. Maertens. 1995. Hepatitis C virus genotyping by means of 5′UR/core line probe assays and molecular analysis of unrypeable samples. Virus Res. 38:137-157.
31. Tanaka, E., K. Kiysawa, A. Matsumoto, T. Sodeyama, A. Urushihara, T. Suzuki, M. Kobayashi, and S. Furuta. 1994. Prevalence of hepatitis C virus with different genotypes determined by a group-specific antibody assay in Japanese patients with chronic liver disease due to hepatitis C virus infection. Jpn. J. Med. Sci. Biol. 47:47-57.
32. Tanaka, T., K. Tsukiyama-Kohara, K. Yamaguchi, S. Vagi, S. Tanaka, A. Hasegawa, Y. Ohta, N. Hattori, and M. Kohara. 1994. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 19:1347-1353.
33. Tsubota, A., K. Chayama, K. Ikeda, A. Yasuji, I. Koida, S. Saitoh, M. Hashimoto, S. Iwasaki, M. Kobayashi, and K. Hiromitsu. 1994. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
34. Tsukiyama-Kohara, K., K. Yamaguchi, N. Maki, Y. Ohta, K. Miki, M. Mizokami, K. Ohba, S. Tanaka, N. Hattori, A. Nomoto, and M. Kohara. 1993. Antigenicities of group I and group II hepatitis C virus polypeptides - molecular basis of diagnosis. Virology 192:430-437.
35. van Doom, L. J., G. E. M. Kleter, L. Stuyver, G. Maertens, J. T. Brouwer, S. W. Schalm, R. A. Heijtink, and W. G. V. Quint. 1994. Analysis of hepatitis C virus genotypes by a line probe assay (LiPA) and correlation with antibody profiles. J. Hepatol. 21:122-129.
36. van Doom, L. J., G. E. M. Kleter, L. Stuyver, G. Maertens, J. T. Brouwer, S. W. Schalm, R. A. Heijtink, and W. G. V. Quint. 1995. Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries. J. Gen. Virol. 76:1871-1876.
37. Yuki, N., N. Hayashi, H. Hagiwara, T. Takehara, K. Katayama, A. Kasahara, H. Fusamoto. and T. Kamada. 1993. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy. Hepatology 17:960-965.
38. Yunomura, K., H. Suguya, T. Harada, F. Tsuda, and H. Okamoto. 1994. Type-specific antibodies to hepatitis C virus in patients with chronic hepatitis C for predicting response to interferon alfa. Int. Hepatol. Commun. 2:201-206.
39. Zaaijer, H. L., H. T. M. Cuypers, H. W. Reesink, I. N. Winkel, G. Gerken, and P. N. Lelie. 1993. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.